Name: Diethyltryptamine
Type: Psychedelic
AKA: DET, N, N-Diethyltryptamine (Positional Isomer: N-Methyl-N-isopropyltryptamine (MiPT))
|
II. Natural Derivative
Synthetic substance, no natural derivative
|
III. Chemical Profile (IUPAC name)
|
IV. History
Diethyltryptamine, a synthetic psychedelic, was first synthesized in the 1970s. It is part of research into new psychoactive substances and their effects on serotonin receptors.
|
V. Legal Information
Diethyltryptamine is a psychedelic compound with hallucinogenic effects. It is classified as a controlled substance in many countries due to its potential for misuse. International regulation reflects concerns about its abuse potential. [Source: UNODC].
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
VI. Physical Effects
Diethyltryptamine (DET) is a psychedelic with effects similar to DMT. It acts as an upper, causing intense hallucinations and altered perception. Short-term use can lead to profound psychological experiences, but long-term effects are not well understood. Overdose risks include severe psychological distress. Safe use is not well-established due to limited research. Recent studies explore its psychoactive effects and potential therapeutic applications. |
VII. Psychological Effects
A powerful hallucinogen that alters perception and cognition. Short-term effects include intense hallucinations and mood changes, while long-term use can lead to persistent psychological effects such as mood disorders. Research emphasizes its impact on serotonin receptors and associated psychological risks.
|
VIII. Culture
Diethyltryptamine (DET), a psychedelic compound, was synthesized in the mid-20th century. It has limited historical lore but is part of the broader context of psychedelic research. Its cultural significance includes its role in discussions about psychedelics and consciousness. Proponents argue for its potential in mental health research, while opponents focus on legal and safety concerns. Its use is primarily in research settings, reflecting ongoing interest in psychedelics.
|